ESTABLISHMENT AND CHARACTERIZATION OF AN IMMATURE MYELOID CELL LINE, M-MOK, GROWN IN THE PRESENCE OF FIBROBLAST-FEEDER CELLS
在成纤维细胞饲养细胞存在下生长的未成熟骨髓细胞系 M-MOK 的建立和表征
基本信息
- 批准号:03454260
- 负责人:
- 金额:$ 3.71万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1991
- 资助国家:日本
- 起止时间:1991 至 1992
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have established an human leukemia cell line, M-MOK, with immature myeloid features. M-MOK was grown only in the presence of human embryonic lung derived fibroblast cell line, HEL-O. Histochemical examination revealed that M-MOK was negative for peroxidase and dougle esterase stains. Surface marker profiles were CD34(+),CD33(+),CD41(+),CD42b(+),HLA-DR(-)and glycophorin (-). We investigated the mechanism of growth for M-MOK cells on HEL-O. Nucleopore membrane was used to examine weather direct contact between M-MOK and HEL-O was required for the growth of M-MOK cells. It was demonstrated that M-MOK was able to grow by soluble factor(s) derived from HEL-O without direct contact. Culture supernatant from HEL-O was harvested and used as conditioned medium(CM). RPMI-1640 medium supplemented with 20% fetal calf serum and 20% CM could induce proliferation of M-MOK cells without feeder cells. We maintained M-MOK cells using this CM supplemented medium as long as 1 month. In order to know the nature of the HEL-O derived soluble factors we tried to inhibit the growth of M-MOK cells on HEL-O using various monoclonal antibodies such as anti-VLA4,anti-CD11a, anti-G-CSF, anti-GM-CSF and anti-IL-3 antibodis. Only anti-GM-CSF antibody inhibited the growth of M-MOK cells. Induction of M-MOK proliferation by HEL-O derived conditioned medium was also blocked by the addition of anti-GM-CSF antibody to the culture medium. These data clearly indicated that the soluble factor from HEL-O which support the growth of M-MOK might be GM-CSF. Northern blot hybridization assay of mRNA from HEL-O confirmed the presence of mRNA for GM-CSF in HEL-O cells.
我们已经建立了具有未成熟髓样特征的人类白血病细胞系M-MOK。 M-MOK仅在人类胚胎肺衍生的成纤维细胞系Hel-O中生长。组织化学检查表明,过氧化物酶和道格酯酶染色的M-MOK为阴性。表面标记物谱为CD34(+),CD33(+),CD41(+),CD42B(+),HLA-DR( - )和糖蛋白( - )。我们研究了M-MOK细胞在HEL-O上的生长机制。核孔膜用于检查M-MOK和HEL-O之间的天气直接接触M-MOK细胞的生长。证明M-MOK能够通过无直接接触的Hel-O得出的可溶性因子(S)生长。收集Hel-O的培养上清液并用作条件培养基(CM)。补充20%胎牛血清和20%CM的RPMI-1640培养基可诱导M-MOK细胞的增殖,而无需进料细胞。我们使用此CM补充培养基维持M-MOK细胞长达1个月。为了了解HEL-O衍生的可溶性因子的性质,我们试图使用各种单克隆抗体(例如抗VLA4,抗CD11A,抗CD11a,anti-G-CSF,anti-GM-CSF,anti-GM-CSF),抗GM-CSF和抗IL-3抗原抑制M-MOK细胞在HEL-O上的生长。仅抗GM-CSF抗体抑制了M-MOK细胞的生长。通过在培养基中添加抗GM-CSF抗体,通过HEL-O衍生的条件培养基诱导M-MOK增殖。这些数据清楚地表明,支持MOK生长的HEL-O的可溶因子可能是GM-CSF。 HEL-O中mRNA的Northern印迹杂交分析证实了HEL-O细胞中GM-CSF的mRNA存在。
项目成果
期刊论文数量(42)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Masayoshi Itano et al.: "Establishment and charactcrization of an immmmature myelovd cell live,M-MOK,grown in the presence of fitroflasts-feeder-cells."
Masayoshi Itano 等人:“未成熟骨髓活细胞 M-MOK 的建立和表征,该细胞在 fitroflasts 饲养细胞存在下生长。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shigeru Tsuchiya: "Bーlineage phenotype of lymphoblastoch cells from patients with xーlinked Agammaglosulinemia" Tohoku J.Exp.Meal.163. 289-294 (1991)
Shigeru Tsuchiya:“来自 x 连锁无丙球蛋白血症患者的淋巴母细胞细胞的 B 谱系表型”Tohoku J.Exp.Meal.163 (1991)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Masayoshi Itano et al.: "Mass Screening for neuroblastima in Miyagi Prefecture."
Masayoshi Itano 等人:“宫城县神经母细胞瘤的大规模筛查。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Masayoshi Minegishi et al.: "A Japanese family pedigree of patients with severe combined immmmunodeficiency clisease with X-linked in heritance" Jap.J.Heem.Genet.36. 137-142 (1991)
Masayoshi Minegishi 等人:“具有 X 连锁遗传的严重联合免疫缺陷病患者的日本家族谱系”Jap.J.Heem.Genet.36。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yuzo Jwoski et al.: "Subaoute paneneephalitis ossociated with chronie GVHD" Eur.J.Potholgy.
Yuzo Jwoski 等人:“与慢性 GVHD 相关的 Subaoute 全脑炎”Eur.J.Potholgy。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TSUCHIYA Shigeru其他文献
TSUCHIYA Shigeru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TSUCHIYA Shigeru', 18)}}的其他基金
Homologous recombination-mediated gene correction in iPS cells o Ornithine transcarbamylase deficiency
iPS 细胞中同源重组介导的基因校正 o 鸟氨酸转氨甲酰酶缺陷
- 批准号:
23659511 - 财政年份:2011
- 资助金额:
$ 3.71万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Leukemogenesis due to insertional mutagenesis-a NOG mouse model-
插入突变引起的白血病发生-NOG小鼠模型-
- 批准号:
19390280 - 财政年份:2007
- 资助金额:
$ 3.71万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Induction of human cytotoxic T cells by peptide-pulsed universal antigen presenting cells
肽脉冲通用抗原呈递细胞诱导人细胞毒性 T 细胞
- 批准号:
16390294 - 财政年份:2004
- 资助金额:
$ 3.71万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
GENE THERAPY FOR X-LINKED SEVERE COMBINED IMMUNODEFICIENCY DISEASE
X连锁严重联合免疫缺陷病的基因治疗
- 批准号:
14370240 - 财政年份:2002
- 资助金额:
$ 3.71万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
MECHANISM OF INFECTION OF EPSTEIN-BARR VIRUS TO T AND NK CELLS
EB病毒感染T细胞和NK细胞的机制
- 批准号:
12470165 - 财政年份:2000
- 资助金额:
$ 3.71万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
TARGET CELL SPECIFIC GENE TRANSFER BY ANTIFECTION AND REGULATION OF PROLIFERATION OF CANCER CELLS
通过抑制和调节癌细胞增殖进行靶细胞特异性基因转移
- 批准号:
10470173 - 财政年份:1998
- 资助金额:
$ 3.71万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Function of the gene of Wiskott-Aldrich syndrome
Wiskott-Aldrich 综合征基因的功能
- 批准号:
08457219 - 财政年份:1996
- 资助金额:
$ 3.71万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
PURIFICATION OF HEMATOPOIETIC STEM CELLS BY A CD117 MONOCLONAL ANTIBODY,MTK1, IN ORDER TO TRANSFECT HUMAN GENES-A PRELIMINARY STUDY
CD117单克隆抗体MTK1纯化造血干细胞转染人类基因的初步研究
- 批准号:
06454295 - 财政年份:1994
- 资助金额:
$ 3.71万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Etiology of congenital agammaglobulinemia: Growth defect of precursor B lymphoblastoid cell lines and immunoglobulin gene rearrangements.
先天性无丙种球蛋白血症的病因:前体 B 淋巴母细胞系的生长缺陷和免疫球蛋白基因重排。
- 批准号:
62480224 - 财政年份:1987
- 资助金额:
$ 3.71万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)